The complement factor B inhibitor iptacopan for relapsed and refractory immune thrombotic thrombocytopenic purpura. [PDF]
Zhou M +7 more
europepmc +1 more source
Acquired Thrombotic Thrombocytopenic Purpura with a Poor Response to Treatment can be an Initial Manifestation of Occult Signet Ring Cell Carcinoma and other Malignancies. [PDF]
Ahmad M +4 more
europepmc +1 more source
Late Onset of Congenital TTP: Case Presentation and Review of the Literature. [PDF]
Chatzisfetkos A, Bergmann C, Janssen U.
europepmc +1 more source
Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calvé-Perthes disease)? [PDF]
Laemmle A, Lämmle B.
europepmc +1 more source
The relationships between disseminated intravascular coagulation and time series change of Von Willebrand factor in patients with out-of-hospital cardiac arrest: a retrospective observational study. [PDF]
Itagaki Y +5 more
europepmc +1 more source
Association between neutrophil extracellular traps, the Von Willebrand factor axis, and clinical outcome in stable coronary artery disease. [PDF]
Bratseth V +7 more
europepmc +1 more source
Clusterin maintains hemostatic equilibrium by stabilizing VWF multimers in plasma.
Qiao Z +11 more
europepmc +1 more source
Case Series and Literature Narrative Review of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Children. [PDF]
Radu LE +9 more
europepmc +1 more source
Thrombotic Thrombocytopenic Purpura in a Patient With Triple-Negative Breast Cancer Treated With PD-L1 Inhibition and Taxane Chemotherapy. [PDF]
Ke J +7 more
europepmc +1 more source
Purpura thrombopénique thrombotique immunologique chez un homme de 35 ans présentant des urines foncées. [PDF]
Bhangu G, Arreglo R, Merkeley H.
europepmc +1 more source

